Related Experiment Video
Updated: Sep 6, 2025

10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
18.3K
Mean Arc Distance (MAD): a quantity to compare trajectory 4πsampling in single target cranial stereotactic
R Lee MacDonald1,2,3, John Lincoln1, Cody Church1
1Department of Physics and Atmospheric Science, Dalhousie University, Canada.
Biomedical Physics & Engineering Express
|June 28, 2022
Summary
A new metric, mean arc distance (MAD), quantifies 4π space sampling in radiotherapy. Decreasing MAD correlates with reduced radiation dose to organs at risk, improving treatment planning.
Area of Science:
- Medical Physics
- Radiation Oncology
- Radiotherapy Planning
Background:
- C-arm linac-based radiotherapy utilizes 4π methods for improved dose delivery.
- Simultaneous couch and gantry rotations aim to spare organs-at-risk (OARs) and enhance dose compactness.
- Current methods often rely on heuristics and trajectory restrictions, lacking a metric for sampling efficiency.
Purpose of the Study:
- To develop a quantitative metric for comparing 4π space sampling in radiotherapy trajectories.
- To assess this metric's utility as a surrogate for dosimetric compactness and OAR sparing.
Main Methods:
- Evenly spaced sampling points were distributed across a 4π sphere.
- The mean arc distance (MAD) metric was defined to quantify the average distance to the nearest field.
- MAD's relationship with isodose volume was analyzed across 2,047 radiotherapy plans, including DCA and VMAT techniques.
Main Results:
- All isodose volumes above 10% of prescription dose decreased exponentially with decreasing MAD.
- Increased 4π sampling, indicated by lower MAD, led to absolute isodose volume reductions, particularly for larger targets.
- Conversely, very low isodoses (0-10%) increased as MAD decreased.
Conclusions:
- Mean arc distance (MAD) effectively quantifies 4π sampling efficiency in radiotherapy.
- MAD serves as a valuable tool for comparing dynamic trajectories and predicting normal tissue sparing.
- This metric shows promise for optimizing cranial radiotherapy and potentially other treatment sites.

